Humalog and Red cell distribution width increased - a phase IV clinical study of FDA data

Summary:

Red cell distribution width increased is found among people who take Humalog, especially for people who are female, 60+ old.

The phase IV clinical study analyzes which people take Humalog and have Red cell distribution width increased. It is created by eHealthMe based on reports of 125,852 people who have side effects when taking Humalog from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 12, 2022

125,852 people reported to have side effects when taking Humalog.
Among them, 31 people (0.02%) have Red cell distribution width increased.


What is Humalog?

Humalog has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 118,881 Humalog users for its effectiveness, alternative drugs and more.

What is Red cell distribution width increased?

Red cell distribution width increased is found to be associated with 816 drugs and 508 conditions by eHealthMe.

Number of Humalog and Red cell distribution width increased reports submitted per year:

Could Humalog cause Red cell distribution width increased?

Gender of people who have Red cell distribution width increased when taking Humalog *:

  • female: 60.87 %
  • male: 39.13 %

Age of people who have Red cell distribution width increased when taking Humalog *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 4.35 %
  • 20-29: 0.0 %
  • 30-39: 8.7 %
  • 40-49: 4.35 %
  • 50-59: 17.39 %
  • 60+: 65.22 %

Common drugs people take besides Humalog *:

  1. Lantus: 15 people, 48.39%
  2. Pantoprazole: 14 people, 45.16%
  3. Gliclazide: 13 people, 41.94%
  4. Vitamin D3: 13 people, 41.94%
  5. Atrovent: 12 people, 38.71%
  6. Lasix: 12 people, 38.71%
  7. Prednisone: 11 people, 35.48%
  8. Synthroid: 11 people, 35.48%
  9. Dilaudid: 10 people, 32.26%
  10. Linagliptin: 10 people, 32.26%

Common side effects people have besides Red cell distribution width increased *:

  1. Breathing Difficulty: 19 people, 61.29%
  2. Blood Pressure Systolic Increased: 19 people, 61.29%
  3. Monocyte Count Increased: 16 people, 51.61%
  4. Mean Cell Haemoglobin Concentration Decreased (less concentration of haemoglobin in a given volume of packed red blood cells): 14 people, 45.16%
  5. Blood Glucose Increased: 14 people, 45.16%
  6. Blood Creatinine Increased: 14 people, 45.16%
  7. Blood Albumin Decreased: 13 people, 41.94%
  8. Dehydration (dryness resulting from the removal of water): 13 people, 41.94%
  9. Haematocrit Decreased: 13 people, 41.94%
  10. Neutrophil Count Increased (excess than normal number of neutrophil a type of blood cell): 13 people, 41.94%

Common conditions people have *:

  1. Vasculitis (inflammation of a blood vessel or blood vessels): 10 people, 32.26%
  2. Depression: 5 people, 16.13%
  3. Colitis (inflammation of colon): 5 people, 16.13%
  4. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 5 people, 16.13%
  5. Gout (uric acid crystals building up in the body): 5 people, 16.13%
  6. Arrhythmias (irregular heartbeat): 3 people, 9.68%
  7. Lymphoproliferative Disorder (a medical condition in which the immune system makes too many white blood cells): 2 people, 6.45%
  8. Stress And Anxiety: 2 people, 6.45%
  9. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 3.23%
  10. Dry Mouth: 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Humalog and have Red cell distribution width increased?

Check whether Red cell distribution width increased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Red cell distribution width increased and when was it recovered:

Expand to all the drugs that have ingredients of insulin lispro recombinant:

Alternative drugs to, pros and cons of Humalog:

Common Humalog side effects:

Browse all side effects of Humalog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Red cell distribution width increased treatments and more:

COVID vaccines that are related to Red cell distribution width increased:

Common drugs associated with Red cell distribution width increased:

All the drugs that are associated with Red cell distribution width increased:

Common conditions associated with Red cell distribution width increased:

All the conditions that are associated with Red cell distribution width increased:

How the study uses the data?

The study uses data from the FDA. It is based on insulin lispro recombinant (the active ingredients of Humalog) and Humalog (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: